ITMI20010985A0 - Farmaci per il morbo di alzheimer - Google Patents

Farmaci per il morbo di alzheimer

Info

Publication number
ITMI20010985A0
ITMI20010985A0 IT2001MI000985A ITMI20010985A ITMI20010985A0 IT MI20010985 A0 ITMI20010985 A0 IT MI20010985A0 IT 2001MI000985 A IT2001MI000985 A IT 2001MI000985A IT MI20010985 A ITMI20010985 A IT MI20010985A IT MI20010985 A0 ITMI20010985 A0 IT MI20010985A0
Authority
IT
Italy
Prior art keywords
alzheimer
drugs
disease
Prior art date
Application number
IT2001MI000985A
Other languages
English (en)
Inventor
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Priority to IT2001MI000985A priority Critical patent/ITMI20010985A1/it
Publication of ITMI20010985A0 publication Critical patent/ITMI20010985A0/it
Priority to PCT/EP2002/005165 priority patent/WO2002092072A2/en
Priority to AU2002312897A priority patent/AU2002312897A1/en
Publication of ITMI20010985A1 publication Critical patent/ITMI20010985A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IT2001MI000985A 2001-05-15 2001-05-15 Farmaci per il morbo di alzheimer ITMI20010985A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2001MI000985A ITMI20010985A1 (it) 2001-05-15 2001-05-15 Farmaci per il morbo di alzheimer
PCT/EP2002/005165 WO2002092072A2 (en) 2001-05-15 2002-05-10 Drugs for the treatment of the alzheimer disease
AU2002312897A AU2002312897A1 (en) 2001-05-15 2002-05-10 Drugs for the treatment of the alzheimer disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000985A ITMI20010985A1 (it) 2001-05-15 2001-05-15 Farmaci per il morbo di alzheimer

Publications (2)

Publication Number Publication Date
ITMI20010985A0 true ITMI20010985A0 (it) 2001-05-15
ITMI20010985A1 ITMI20010985A1 (it) 2002-11-15

Family

ID=11447649

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001MI000985A ITMI20010985A1 (it) 2001-05-15 2001-05-15 Farmaci per il morbo di alzheimer

Country Status (3)

Country Link
AU (1) AU2002312897A1 (it)
IT (1) ITMI20010985A1 (it)
WO (1) WO2002092072A2 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1476168A2 (en) 2002-02-04 2004-11-17 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
US7163958B2 (en) 2002-07-03 2007-01-16 Nitromed Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
WO2004010945A2 (en) 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
US20040138296A1 (en) * 2002-08-12 2004-07-15 Pharmacia Corporation Amyloid immunization and Cox-2 inhibitors for the treatment of alzheimer's disease
ITMI20021861A1 (it) * 2002-08-29 2004-02-29 Nicox Sa Procedimento di sintesi di nitrossialchilesteri di acidi carbossilici, intermedi impiegabili in detto procedimento e loro preparazione.
EP1709155B1 (en) * 2003-12-31 2013-10-02 Chesterford Enterprises Limited Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
CA2577490A1 (en) 2004-08-26 2006-03-16 Nicholas Piramal India Limited Prodrugs containing alkyldisulfide linker groups
GB0606015D0 (en) 2006-03-28 2006-05-03 Merck Sharp & Dohme therapeutic agents
CA2679955A1 (en) * 2006-10-13 2008-05-29 Reliance Life Sciences Pvt. Ltd. Novel chemotherapeutic agents against inflammation and cancer
AU2008215948A1 (en) 2007-02-12 2008-08-21 Merck & Co., Inc. Piperazine derivatives for treatment of AD and related conditions
EP2167070A1 (en) 2007-07-09 2010-03-31 Nicox S.A. Use of nitric oxide releasing compounds in the treatment of chronic pain
EP2180788B1 (en) 2007-08-10 2016-12-21 Basil Rigas Anti-inflammatory compounds and uses thereof
WO2010071741A1 (en) 2008-12-16 2010-06-24 Merck Sharp & Dohme Corp. Triazole derivatives for treatment of alzheimer's disease
PT2699242T (pt) 2011-04-19 2018-01-22 Alfama Inc Moléculas de libertação de monóxido de carbono e utilizações das mesmas
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
WO2017096049A1 (en) 2015-12-03 2017-06-08 The University Of North Carolina At Pembroke Materials for cathepsin b enhancement and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192753A (en) * 1991-04-23 1993-03-09 Mcgeer Patrick L Anti-rheumatoid arthritic drugs in the treatment of dementia
IT1256345B (it) * 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.

Also Published As

Publication number Publication date
WO2002092072A2 (en) 2002-11-21
WO2002092072A3 (en) 2003-05-01
ITMI20010985A1 (it) 2002-11-15
AU2002312897A1 (en) 2002-11-25

Similar Documents

Publication Publication Date Title
EE200200716A (et) Ühendid Alzheimeri tõve käitluseks
NO20033556L (no) Farmasöytiske formuleringer
ITMI20010985A0 (it) Farmaci per il morbo di alzheimer
ITVR20010019A0 (it) "contrafforte per calzature"
NO20033384L (no) Farmasoytisk formulering
EE200300416A (et) Ravimvorm
AU2002353378A8 (en) Vaccine for periodontal disease
NO20035627D0 (no) Farmasöytisk formulering
FR2863887B1 (fr) Procede d'innoformulation d'une base galenique biocompatible
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
ITMI20011307A0 (it) Farmaci per l'epilessia
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
NO20035352L (no) Legemidler for eosinofile sykdommer
MA27240A1 (fr) Derives d'imidazoquinoleine
AU2003251962A8 (en) Screening for alzheimer's disease
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
AU2002364885A8 (en) Alzheimer's disease model
GB0012123D0 (en) Alzheimer's disease assay
ITPI20020047A1 (it) "sostegno sagomato per scarpe"
GB0127473D0 (en) Compounds for imaging alzheimer's disease
ITMI20010196U1 (it) Apparato per l' effettuazione di idromassaggi.
UA5182S (uk) Флакон для ліків «лів-52»
UA5906S (uk) Емблема «віта ольвія»
UA7706S (uk) Пляшка для ліків «глікодин»
GB0203391D0 (en) Compounds for imaging alzheimer's disease